Form S-3ASR Avalo Therapeutics, Inc.
http://archive.fast-edgar.com/20261105/A4B2922D8M22K2Z2222O22ZZDPT9R2X2X282
Filed on: November 5, 2026
Form 10-Q GIBRALTAR INDUSTRIES, For: Sep 30
http://archive.fast-edgar.com/20261105/AI25H222H222D2T2222A2CO2BUWQZ222B282
Filed on: November 5, 2026
Form 6-K Hesai Group For: Nov 05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2026
Commission File Number: 001-41611
Hesai Group
10th Floor, Building A
No. 658 Zhaohua Road, Changning District
Shanghai 200050
People’s Republic of China
(Address of principal executive... (continue reading...)
Form 8-K INTENSITY THERAPEUTICS, For: Nov 05
0001567264FALSE00015672642026-11-052026-11-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 5, 2026Intensity Therapeutics, Inc.(Exact name of Registrant as Specified in Its Charter)Delaware001-4110946-1488089(State or Other Jurisdictionof Incorporation) (Commission File Number) (IRS... (continue reading...)
Form 8-K ACI WORLDWIDE, INC. For: Nov 05
0000935036false00009350362026-11-052026-11-050000935036exch:XNGS2026-11-052026-11-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549___________________________FORM 8-K ___________________________CURRENT REPORTPursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 5, 2026Commission File Number 0-25346 ACI WORLDWIDE, INC. (Exact name of registrant as specified in its charter)... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K Gildan Activewear Inc. For: Sep 27
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 8-K Parker-Hannifin Corp For: Nov 05
-
Form 10-Q SONIDA SENIOR LIVING, For: Sep 30
-
Form 10-Q Lantheus Holdings, Inc. For: Sep 30
-
Form 6-K BCE INC For: Sep 30
-
Form 6-K WOODSIDE ENERGY GROUP For: Nov 05
-
Form 10-Q Acadian Asset Management For: Sep 30
-
Form 424B5 Avalo Therapeutics, Inc.
-
Form S-3ASR Climb Bio, Inc.
-
Form 6-K Gildan Activewear Inc. For: Sep 27
-
Form 424B3 1st FRANKLIN FINANCIAL
-
Form 8-K CUMMINS INC For: Nov 05
-
Form 8-K Enviri Corp For: Nov 05
-
Form 10-Q Distribution Solutions For: Sep 30
-
Form 13F-HR swisspartners Advisors For: Sep 30
-
Form 6-K Himax Technologies, Inc. For: Nov 05
-
Form 8-K Viatris Inc For: Nov 05
-
Form 10-Q Pyxis Oncology, Inc. For: Sep 30
-
Form 6-K IsoEnergy Ltd. For: Nov 05
-
Form 8-K Cars.com Inc. For: Nov 05
-
Form 8-K STEVEN MADDEN, LTD. For: Nov 05
-
Form 8-K ACM Research, Inc. For: Nov 05
-
Form 8-K GIBRALTAR INDUSTRIES, For: Nov 05
-
Form D/A MCP Emerging Markets
-
Form 8-K Sabre Corp For: Nov 05
-
Form 8-K KELLY SERVICES INC For: Nov 05
-
Form 8-K Lantheus Holdings, Inc. For: Nov 05
-
Form 10-Q INTENSITY THERAPEUTICS, For: Sep 30
-
Form 8-K Distribution Solutions For: Nov 05
-
Form 10-12B/A Biointra, Corp
-
Form 8-K Enovix Corp For: Nov 05
-
Form 8-K Pyxis Oncology, Inc. For: Nov 05
-
Form 8-A12B Wendy's Co
-
Form 8-K GIBRALTAR INDUSTRIES, For: Nov 05
-
Form 6-K FIRST MAJESTIC SILVER For: Nov 04
-
Form 8-K Teads Holding Co. For: Nov 05
-
Form 10-Q Akebia Therapeutics, For: Sep 30
-
Form 4 CRH PUBLIC LTD CO For: Nov 03 Filed by: Talbot Siobhan
-
Form 8-K ALNYLAM PHARMACEUTICALS, For: Nov 02
-
Form 6-K HSBC HOLDINGS PLC For: Nov 05
-
Form 6-K Canada Goose Holdings For: Sep 27
-
Form 10-Q SAB Biotherapeutics, For: Sep 30
-
Form 10-Q ARROW ELECTRONICS, INC. For: Oct 03
-
Form 8-K Payoneer Global Inc. For: Nov 05
-
Form 8-K Dyne Therapeutics, Inc. For: Nov 05
-
Form 8-K Advanced Flower Capital For: Nov 05
-
Form 6-K Marex Group Ltd For: Sep 30
-
Form 10-Q Cabaletta Bio, Inc. For: Sep 30
-
Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30
